CORAL Renal Trial To Show Risks, Benefits Of Stenting Over Drugs

The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial likely will provide the first definitive evidence on the benefits of renal stenting, according to Julio Palmaz, MD, University of Texas

More from Archive

More from Medtech Insight